Menu

Procalcitonin (PCT): A Vital Biomarker in Infectious Disease Management

Cardiac Markers

Biochemistry and Synthesis

    • Procalcitonin (PCT) is a 116-residue peptide, the pro-hormone of calcitonin, with a molecular mass of about 13 kDa.
    • Normally synthesized in the thyroid gland's C-cells, but production is complex and upregulated during systemic infections, particularly bacterial.
    • Also synthesized by liver, kidney, adipocytes, and muscle cells when stimulated by inflammatory mediators like endotoxins and cytokines (TNF-α, IL-1β, IL-6).
    • Escapes normal post-translational processing during infection, released into circulation as the intact prohormone.

Diagnostic Value in Bacterial Infections

    • Useful biomarker for diagnosing bacterial infections and sepsis, more specific than CRP or white blood cell count.
    • PCT levels are suppressed in viral infections and non-infectious inflammatory diseases, aiding in differentiation.
    • Dynamics of PCT:
      • Levels increase within a few hours of infection onset.
      • Peak at 24-48 hours.
      • Decrease rapidly with effective treatment.
    • Normal PCT values: below 0.05 ng/ml.
    • Suggestive of bacterial infection: 0.5 ng/ml or above.
    • Suggestive of sepsis: 2 ng/ml or above.
    • Valuable marker in emergency and intensive care units for timely antibiotic therapy initiation.

Clinical Applications and Decision Making

    • Evolved clinical decision-making:
      • Managing antibiotic therapy initiation and discontinuation.
      • Assessing patient response to treatment.
      • Determining patient prognosis in intensive care.
    • PCT-based algorithms in antibiotic stewardship programs reduce antibiotic use with similar or better patient outcomes.
    • Important amid growing antibiotic resistance issues.

Limitations and Confounding Factors

    • Certain conditions can cause elevated PCT levels without bacterial infection: major trauma, surgery, severe burns, some autoimmune diseases.
    • Some bacterial infections, including localized or intracellular bacteria, may not result in high PCT levels.
    • Renal impairment can alter PCT clearance, raising levels.
    • PCT levels should be assessed alongside clinical and laboratory data for accurate diagnosis.
ENQUIRY FORM

More News

  • TNF Alpha: A Central Mediator of Inflammation and Immune Response

  • Sclerostin (SOST): The Master Regulator of Bone Formation

  • TNFSF11/RANKL: A Key Regulator of Bone Metabolism and Beyond

  • Superoxide Dismutase (SOD): The Body's Powerful Antioxidant Defence System